Nanologica announced that as a result of Nanologica's product in preparative chromatography, NLAB Saga, reaching internal quality requirements, silica is now delivered to a customer in Latin America for production of diabetes drugs. The customer is a latin-american pharmaceutical manufacturer that manufactures, among other things, insulin and insulin analogues. This delivery refers to silica for the production of insulin.

The delivery is made against a recent order with an order value of about SEK 300,000. Several customers have successfully evaluated Nanologica's silica for preparative chromatography, NL AB Saga, in different stages. Last year, the company took multiple orders for large-scale evaluation.